Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 December 2018 | Story Leonie Bolleurs | Photo Leonie Bolleurs
Mpho Makgalemele
Mpho Makgalemele, town planner at Emalahleni Local Municipality, developed perseverance, tactical thinking and problem-solving skills when she enrolled for the Professional Master’s in Urban and Regional Planning.

Mpho Makgalemele received her Master’s degree at the December Graduation Ceremonies of the University of the Free State (UFS). The highlight of walking up to the stage to receive her Master’s degree in Urban and Regional Planning marked a milestone in Makgalemele’s career.

Her thesis is titled: “The role of town planning in the implementation of the ‘special presidential package for the revitalisation of distressed mining towns’ “: with specific reference to Emalahleni (formerly known as Witbank).

Contributing to township development in SA

She enrolled for the Professional Master’s in Urban and Regional Planning in the Department of Urban and Regional Planning to solve complex spatial planning challenges, thus contributing to the economic and township development of South Africa. “I wanted to advance my technical knowledge, contribute to the urban and regional planning body of knowledge, and practise my profession in a specialised manner,” she said. 

Makgalemele believes that doing a master’s programme builds your character and develops attributes such as perseverance, tactical thinking and problem-solving within you as a person. 

Building intellectual capacity 

Makgalemele is the town planner of Emalahleni Local Municipality and applies on a daily basis the advanced theoretical knowledge of urban planning, the research skills and the writing and presentation skills she obtained in the programme. 

“The programme augments your intellectual capacity. It provides advanced technical skills, knowledge and practical experience that is imperative for town planning professionals,” she said. 

Maléne Campbell, Head of the Department of Urban and Regional Planning has high praise for Makgalemele: “She overcame challenges by managing the spatial planning vulnerabilities (including environmental degradation, service-delivery challenges and a massive population growth) of a local economy based on non-renewable resources, while at the same time doing research for her master’s.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept